Trazocalm®

APVMA-Approved* Trazodone tablets for the veterinary management of anxiety and stress in dogs.

Product Overview

Behavioural anxiety can affect animal wellbeing, compliance with care, and overall treatment outcomes. Trazocalm® is developed to support veterinary professionals in implementing structured behavioural management strategies.

Formulated with clinical application and practical administration in mind, Trazocalm® integrates into veterinary treatment plans where calming support is appropriate.

Key Benefits

For the Patient

  • Supports calmer behaviour during transport and clinical handling.*
  • Encourages rest following procedures to assist recovery.*
  • Fast-acting reducing situational anxiety and fear for safer handling within 30-45 minutes of administration.1
  • Well-tolerated and compatible with NSAIDs/post-op medications.2

For the Clinic

  • Australia’s first APVMA-approved* commercial Trazodone.
  • Precision dosing with half and trisected-tablet flexibility.
  • 36-month shelf life, GMP quality manufacturing, and no compounding required.

Directions for use

Intended to titrate up in dosage.

For transportation and vet visit anxiety1:
Starting dose: 3.5 mg/kg
Regular dosage: 9 – 12 mg/kg
Administer 90 minutes before transportation

For post-operative confinement2:
Starting dose: 3.5 mg/kg
Regular dosage: 7 – 10 mg/kg minimum 4 weeks and up to 12 weeks with repeat scripts, as required.

Read the permit before use here.

Ingredients

Active Constituents:

50 mg/tab Trazodone HCL (45.5 mg trazodone base)
100 mg/tab Trazodone HCL (91.08 mg trazodone base)
150 mg/tab Trazodone HCL (136.62 mg trazodone base)

*Trazocalm® is a veterinary medicine approved under APVMA Permit PER93844. This permit authorises supply of an unregistered product. An application has been made to register the product. References: Kim et al. Effects of trazodone on behavioral and physiological signs of stress in dogs during veterinary visits. Journal AVMA. 2022 Mar 24;260(8):876-883. Gruen M et al. Use of trazodone to facilitate postsurgical confinement in dogs. Journal AVMA. 2014 Aug;245(3):296-301

Download Product Information

Interested in knowing more? Complete the form below to download our product brochure.

"*" indicates required fields

By Submitting your details you agree to receive occasional marketing communications and product updated from InVetro